Dec 20, 2018

Starpharma’s US license for VivaGel® BV covered by Biotech Dispatch

Starpharma’s US license for VivaGel® BV covered by Biotech Dispatch

Biotech Dispatch featured the news that Starpharma had signed a sales and marketing license agreement for VivaGel® BV for the US market with ITF Pharma. The piece highlighted that upon launch, VivalGel® BV will be ITF Pharma’s top priority women’s health product. 

To read the article, click here.

 This contains certain forward-looking statements.